申请人:Calico Life Sciences LLC
公开号:US10954202B2
公开(公告)日:2021-03-23
Provided herein are compounds, compositions, and methods useful for inhibiting protein tyrosine phosphatase, e.g., protein tyrosine phosphatase non-receptor type 2 (PTPN2) and/or protein tyrosine phosphatase non-receptor type 1 (PTPN1), and for treating related diseases, disorders and conditions favorably responsive to PTPN1 or PTPN2 inhibitor treatment, e.g., a cancer or a metabolic disease.
本文提供的化合物、组合物和方法可用于抑制蛋白酪氨酸磷酸酶,例如蛋白酪氨酸磷酸酶非受体2型(PTPN2)和/或蛋白酪氨酸磷酸酶非受体1型(PTPN1),以及治疗对PTPN1或PTPN2抑制剂治疗有良好反应的相关疾病、失调和病症,例如癌症或代谢性疾病。